He continued on levofloxacin for Serratia pneumonia.
Additionally, he was started on prednisone 60 mg PO q d for empiric treatment of Dressler's syndrome.
The patient's case was presented at a pulmonary conference and the consensus of opinion was that he had enough features consistent with Dressler's syndrome, also known as post cardiotomy syndrome, to warrant treatment with steroids.
Additionally, on [**9-18**], the chest x-ray revealed significantly improved pleural effusions and pulmonary infiltrates.
Hematology:  The patient's INR goal at admission was 2.5-3.5, reportedly to anticoagulate him for his mitral valve.
CT Surgery was contact[**Name (NI) **] and they instructed us that, because his mitral valve was a mosaic bioprosthesis, he does not require any anticoagulation for his valve.
In light of this, his only indication for anticoagulation is his atrial fibrillation which requires an INR of [**1-15**].
DISCHARGE MEDICATIONS:  Unchanged from previous summary, with the following exceptions: 1.
Coumadin is now 2.5 mg PO q d.   DISCHARGE DIAGNOSES:  Unchanged from previous summary.
FOLLOW-UP:  Unchanged from previous summary.
